139 related articles for article (PubMed ID: 21546157)
41. Cytosine deaminase and thymidine kinase gene therapy in a Dunning rat prostate tumour model: absence of bystander effects and characterisation of 5-fluorocytosine metabolism with 19F-NMR spectroscopy.
Corban-Wilhelm H; Hull WE; Becker G; Bauder-Wüst U; Greulich D; Debus J
Gene Ther; 2002 Dec; 9(23):1564-75. PubMed ID: 12424609
[TBL] [Abstract][Full Text] [Related]
42. Anti-proliferative Effect of Engineered Neural Stem Cells Expressing Cytosine Deaminase and Interferon-β against Lymph Node-Derived Metastatic Colorectal Adenocarcinoma in Cellular and Xenograft Mouse Models.
Park GT; Kim SU; Choi KC
Cancer Res Treat; 2017 Jan; 49(1):79-91. PubMed ID: 27188205
[TBL] [Abstract][Full Text] [Related]
43. Enhanced EJ Cell Killing of (125)I Radiation by Combining with Cytosine Deaminase Gene Therapy Regulated by Synthetic Radio-Responsive Promoter.
Li L; Zhang CL; Kang L; Wang RF; Yan P; Zhao Q; Yin L; Guo FQ
Cancer Biother Radiopharm; 2015 Oct; 30(8):342-8. PubMed ID: 26382009
[TBL] [Abstract][Full Text] [Related]
44. Bystander effect caused by cytosine deaminase gene and 5-fluorocytosine in vitro is substantially mediated by generated 5-fluorouracil.
Kuriyama S; Masui K; Sakamoto T; Nakatani T; Kikukawa M; Tsujinoue H; Mitoro A; Yamazaki M; Yoshiji H; Fukui H; Ikenaka K; Mullen CA; Tsujii T
Anticancer Res; 1998; 18(5A):3399-406. PubMed ID: 9858915
[TBL] [Abstract][Full Text] [Related]
45. Combination of a fusogenic glycoprotein, prodrug activation, and oncolytic herpes simplex virus for enhanced local tumor control.
Simpson GR; Han Z; Liu B; Wang Y; Campbell G; Coffin RS
Cancer Res; 2006 May; 66(9):4835-42. PubMed ID: 16651439
[TBL] [Abstract][Full Text] [Related]
46. Product release is rate-limiting in the activation of the prodrug 5-fluorocytosine by yeast cytosine deaminase.
Yao L; Li Y; Wu Y; Liu A; Yan H
Biochemistry; 2005 Apr; 44(15):5940-7. PubMed ID: 15823054
[TBL] [Abstract][Full Text] [Related]
47. Glioma cells transduced with an Escherichia coli CD/HSV-1 TK fusion gene exhibit enhanced metabolic suicide and radiosensitivity.
Rogulski KR; Kim JH; Kim SH; Freytag SO
Hum Gene Ther; 1997 Jan; 8(1):73-85. PubMed ID: 8989997
[TBL] [Abstract][Full Text] [Related]
48. Breast cancer-specific expression of the Candida albicans cytosine deaminase gene using a transcriptional targeting approach.
Anderson LM; Krotz S; Weitzman SA; Thimmapaya B
Cancer Gene Ther; 2000 Jun; 7(6):845-52. PubMed ID: 10880014
[TBL] [Abstract][Full Text] [Related]
49. Combined cytosine deaminase expression, 5-fluorocytosine exposure, and radiotherapy increases cytotoxicity to cholangiocarcinoma cells.
Pederson LC; Vickers SM; Buchsbaum DJ; Kancharla SR; Mayo MS; Curiel DT; Stackhouse MA
J Gastrointest Surg; 1998; 2(3):283-91. PubMed ID: 9841986
[TBL] [Abstract][Full Text] [Related]
50. Enzyme Prodrug Therapy with Photo-Cross-Linkable Anti-EGFR Affibodies Conjugated to Upconverting Nanoparticles.
Roy S; Curry SD; Corbella Bagot C; Mueller EN; Mansouri AM; Park W; Cha JN; Goodwin AP
ACS Nano; 2022 Oct; 16(10):15873-15883. PubMed ID: 36129781
[TBL] [Abstract][Full Text] [Related]
51. Cytosine deaminase-producing human mesenchymal stem cells mediate an antitumor effect in a mouse xenograft model.
You MH; Kim WJ; Shim W; Lee SR; Lee G; Choi S; Kim DY; Kim YM; Kim H; Han SU
J Gastroenterol Hepatol; 2009 Aug; 24(8):1393-400. PubMed ID: 19486256
[TBL] [Abstract][Full Text] [Related]
52. Genetic construction, expression, and characterization of a single chain anti-CEA antibody fused to cytosine deaminase from yeast.
Zamboni S; Mallano A; Flego M; Ascione A; Dupuis ML; Gellini M; Barca S; Cianfriglia M
Int J Oncol; 2008 Jun; 32(6):1245-51. PubMed ID: 18497986
[TBL] [Abstract][Full Text] [Related]
53. Quantitation of cytosine deaminase mRNA by real-time reverse transcription polymerase chain reaction: a sensitive method for assessing 5-fluorocytosine toxicity in vitro.
Miller CR; Gustin AN; Buchsbaum DJ; Vickers SM; Manne U; Grizzle WE; Cloud GA; Diasio RB; Johnson MR
Anal Biochem; 2002 Feb; 301(2):189-99. PubMed ID: 11814289
[TBL] [Abstract][Full Text] [Related]
54. Enzyme/prodrug gene therapy approach for breast cancer using a recombinant adenovirus expressing Escherichia coli cytosine deaminase.
Li Z; Shanmugam N; Katayose D; Huber B; Srivastava S; Cowan K; Seth P
Cancer Gene Ther; 1997; 4(2):113-7. PubMed ID: 9080120
[TBL] [Abstract][Full Text] [Related]
55. Escherichia coli cytosine deaminase: Structural and biotechnological aspects.
Vosough P; Vafadar A; Naderi S; Alashti SK; Karimi S; Irajie C; Savardashtaki A; Taghizadeh S
Biotechnol Appl Biochem; 2024 Feb; 71(1):5-16. PubMed ID: 37743549
[TBL] [Abstract][Full Text] [Related]
56. Therapeutic Efficacy of Prodrug Activator Gene Therapy Using Retroviral Replicating Vectors for Human Ovarian Cancer.
Isoda L; Sonoda-Fukuda E; Fujino H; Takarada T; Hasegawa K; Kasahara N; Kubo S
Anticancer Res; 2023 Dec; 43(12):5311-5317. PubMed ID: 38030176
[TBL] [Abstract][Full Text] [Related]
57. Yeast cytosine deaminase improves radiosensitization and bystander effect by 5-fluorocytosine of human colorectal cancer xenografts.
Kievit E; Nyati MK; Ng E; Stegman LD; Parsels J; Ross BD; Rehemtulla A; Lawrence TS
Cancer Res; 2000 Dec; 60(23):6649-55. PubMed ID: 11118048
[TBL] [Abstract][Full Text] [Related]
58. Synergistic effects of genetically engineered stem cells expressing cytosine deaminase and interferon-β via their tumor tropism to selectively target human hepatocarcinoma cells.
Yi BR; Hwang KA; Kang NH; Kim SU; Jeung EB; Kim HC; Choi KC
Cancer Gene Ther; 2012 Sep; 19(9):644-51. PubMed ID: 22790964
[TBL] [Abstract][Full Text] [Related]
59. Photodynamic therapy-driven induction of suicide cytosine deaminase gene.
Bil J; Wlodarski P; Winiarska M; Kurzaj Z; Issat T; Jozkowicz A; Wegiel B; Dulak J; Golab J
Cancer Lett; 2010 Apr; 290(2):216-22. PubMed ID: 19822393
[TBL] [Abstract][Full Text] [Related]
60. Effects of genetically engineered stem cells expressing cytosine deaminase and interferon-beta or carboxyl esterase on the growth of LNCaP rrostate cancer cells.
Yi BR; Hwang KA; Kim YB; Kim SU; Choi KC
Int J Mol Sci; 2012 Sep; 13(10):12519-32. PubMed ID: 23202910
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
